Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs738409
rs738409
0.040 GeneticVariation BEFREE I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders. 26765961

2016

dbSNP: rs738409
rs738409
0.040 GeneticVariation BEFREE I148M variant in PNPLA3 reduces central adiposity and metabolic disease risks while increasing nonalcoholic fatty liver disease. 26148225

2015

dbSNP: rs738409
rs738409
0.040 GeneticVariation BEFREE In Inter99, we analyzed associations of rs738409 with components of the WHO-defined metabolic syndrome (n = 5,847) and traits related to metabolic disease (n = 5,663). 22792295

2012

dbSNP: rs738409
rs738409
0.040 GeneticVariation BEFREE The lack of a relationship with visceral obesity and the inverse correlation with CIMT suggest that fatty liver associated with the minor G allele of the PNPLA3 rs738409 polymorphism may not be linked to metabolic disorders. 20826584

2010

dbSNP: rs854560
rs854560
0.020 GeneticVariation BEFREE L55M polymorphism, like exposure to tobacco smoke and overweight, disorders PON1 status and lipid profile parameters; therefore, it could be a crucial risk factor for the development of many metabolic disorders. 30618305

2019

dbSNP: rs8192678
rs8192678
0.020 GeneticVariation BEFREE Linking Metabolic Disease With the PGC-1α Gly482Ser Polymorphism. 29186342

2018

dbSNP: rs2059806
rs2059806
0.020 GeneticVariation BEFREE Thus, it was found that the INSR rs2059806 SNP is also associated with pre-eclampsia phenotypes in two independent cohorts suggesting that genetic susceptibility may be implicated in the link between pre-eclampsia and subsequent vascular and metabolic diseases. 28117222

2017

dbSNP: rs4994
rs4994
0.020 GeneticVariation BEFREE The aim of this study was to determine the relationship between PPAR gamma-2 (Pro12Ala, C1431T) and ADRB3 (Trp64Arg) polymorphisms and serum adipocytokines (adiponectin, visfatin, and resistin) and metabolic disorders in 176 postmenopausal women with increased body mass (BMI ≥ 25 kg m(-2)). 27246401

2016

dbSNP: rs2059806
rs2059806
0.020 GeneticVariation BEFREE The INSR rs2059806 SNP previously associated with adult vascular and metabolic diseases is also associated with SGA pregnancies. 26089371

2015

dbSNP: rs1801282
rs1801282
0.020 GeneticVariation BEFREE Thus, PPARγ2 rs1801282 polymorphism may play a significant role in the development of metabolic disorders in HIV/HCV coinfected patients, and might have an influence on the cardiovascular risk. 25159899

2014

dbSNP: rs854560
rs854560
0.020 GeneticVariation BEFREE None of the variants of the Leu55Met PON1 polymorphism was associated with more frequent occurrence of PCOS or metabolic disorders, including insulin resistance. 20334584

2010

dbSNP: rs1801282
rs1801282
0.020 GeneticVariation BEFREE In conclusion, the PPARG Pro12Ala polymorphism might represent a genetic susceptibility factor for preterm birth and constitute a link between preterm birth and metabolic diseases later in life. 17259396

2007

dbSNP: rs8192678
rs8192678
0.020 GeneticVariation BEFREE Our findings confirm that sex and age should be considered when investigating the influence of the PPARGC1A Gly482Ser polymorphism on metabolic disease. 16474966

2006

dbSNP: rs4994
rs4994
0.020 GeneticVariation BEFREE Our results suggest that the Trp64Arg mutation is not a major determinant of metabolic disorders (type 2 diabetes, obesity) and chronic complications of type 2 diabetes in a Dutch population. 11213599

2001

dbSNP: rs10830963
rs10830963
0.010 GeneticVariation BEFREE Our study found that MTNR1A rs2119882 and MTNR1B rs10830963 could increase the risk for PCOS and cause glycolipid metabolism disorder in PCOS patients. 30664204

2019

dbSNP: rs182052
rs182052
0.010 GeneticVariation BEFREE Thus, the results indicate that minor A allele of rs182052 of the <i>ADIPOQ</i> gene is significantly associated with a decrease in serum adiponectin levels, and two SNPs (rs182052 and rs266729) of the <i>ADIPOQ</i> gene are significantly associated with cardiovascular and metabolic diseases. 31561637

2019

dbSNP: rs2119882
rs2119882
0.010 GeneticVariation BEFREE Our study found that MTNR1A rs2119882 and MTNR1B rs10830963 could increase the risk for PCOS and cause glycolipid metabolism disorder in PCOS patients. 30664204

2019

dbSNP: rs2331841
rs2331841
0.010 GeneticVariation BEFREE Our data first suggest that SNPs in the rs2331841 site of the <i>MC4R</i> gene are closely related to obesity and its related metabolic disorders in Chinese Northern Han populations. 31781208

2019

dbSNP: rs266729
rs266729
0.010 GeneticVariation BEFREE Thus, the results indicate that minor A allele of rs182052 of the <i>ADIPOQ</i> gene is significantly associated with a decrease in serum adiponectin levels, and two SNPs (rs182052 and rs266729) of the <i>ADIPOQ</i> gene are significantly associated with cardiovascular and metabolic diseases. 31561637

2019

dbSNP: rs1799883
rs1799883
0.010 GeneticVariation BEFREE This study aimed to determine whether FABP2 (Ala54Thr) and MTTP (-493 G/T) genetic polymorphisms are associated with metabolic disorders in Mexican subjects. 29338565

2018

dbSNP: rs6265
rs6265
0.010 GeneticVariation BEFREE Plasma BDNF levels and a functional <i>BDNF</i> Val66Met (rs6265) polymorphism were reported to be associated with PTSD, as well as with increased body mass index (BMI) and dyslipidaemia in healthy subjects and patients with cardio-metabolic diseases, but these results are controversial. 30542302

2018

dbSNP: rs9939609
rs9939609
FTO
0.010 GeneticVariation BEFREE No direct relationships were demonstrated between MetS and the gene polymorphisms analyzed in our study except for the <i>FTO</i> rs9939609, whose A allele and A/A genotype seemed to predispose to metabolic disorders. 30271660

2018

dbSNP: rs1267969615
rs1267969615
ACE
0.010 GeneticVariation BEFREE The aim of the study was to investigate the association between ACE (I/D) and AGT (M235T) gene polymorphisms and cardiovascular and metabolic disorders in the acromegaly. 28712073

2017

dbSNP: rs150924946
rs150924946
0.010 GeneticVariation BEFREE Interestingly, this study also correlated novel variant p.K108E with psychiatric disease, identified known variant p.I299V as a potential risk factor for metabolic disease in Latinos, linked variant p.G602 with type 2 diabetes, and identified p.G602S as a predictor of diabetes risk in African Americans. 28663758

2017

dbSNP: rs16139
rs16139
0.010 GeneticVariation BEFREE A gain-of-function polymorphism in human neuropeptide Y (<i>NPY</i>) gene (rs16139) associates with metabolic disorders and earlier onset of type 2 diabetes (T2D). 28468933

2017